Recommended Readings: Jeffrey V. Ravetch, M.D., Ph.D., February 13, 2023

Recommended Readings: Jeffrey V. Ravetch, M.D., Ph.D., February 13, 2023

Monday Lecture Series

(open to the Rockefeller community)

Monday, February 13, 2023

Jeffrey V. Ravetch, M.D., Ph.D.

Theresa and Eugene M. Lang Professor,
Head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology,
The Rockefeller University

 

Diversity of Antibody Effector Functions

Recommended Readings:

Empirical Articles

Kao, K. S., Gupta, A., Zong, G., Li, C., Kerschbaumer, I., Borghi, S., Achkar, J. M., Bournazos, S., Wang, L. X., & Ravetch, J. V. (2022). Synthetic nanobodies as tools to distinguish IgG Fc glycoforms. Proceedings of the National Academy of Sciences of the United States of America, 119(48), e2212658119.

Gupta, A., Smith, P., Bournazos, S., & Ravetch, J. V. (2022). A novel mouse strain optimized for chronic human antibody administration. Proceedings of the National Academy of Sciences of the United States of America, 119(10), e2123002119.

Yamin, R., Jones, A. T., Hoffmann, H. H., Schäfer, A., Kao, K. S., Francis, R. L., Sheahan, T. P., Baric, R. S., Rice, C. M., Ravetch, J. V., & Bournazos, S. (2021). Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy. Nature, 599(7885), 465–470.

Li, C., Chong, G., Zong, G., Knorr, D. A., Bournazos, S., Aytenfisu, A. H., Henry, G. K., Ravetch, J. V., MacKerell, A. D., Jr, & Wang, L. X. (2021). Site-Selective Chemoenzymatic Modification on the Core Fucose of an Antibody Enhances Its Fcγ Receptor Affinity and ADCC Activity. Journal of the American Chemical Society, 143(20), 7828–7838.

Nimmerjahn, F., & Ravetch, J. V. (2021). Four keys to unlock IgG. The Journal of experimental medicine, 218(3), e20201753.

By |2023-01-23T16:28:36+00:00January 23rd, 2023|Categories: Immunology, Molecular Genetics, Monday Lectures|Tags: |Comments Off on Recommended Readings: Jeffrey V. Ravetch, M.D., Ph.D., February 13, 2023

About the Author: